MedPath

MERZ NORTH AMERICA, INC.

MERZ NORTH AMERICA, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
1908-01-01
Employees
501
Market Cap
-
Website
http://www.merzusa.com

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Not Applicable
Completed
Conditions
Injection Site Reaction
Interventions
Device: Injection
First Posted Date
2023-10-23
Last Posted Date
2024-12-13
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
20
Registration Number
NCT06093815
Locations
🇪🇸

Ocean Clinic - Av. Ramon y Cajal 7, 29601, Marbella, Spain

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

Phase 1
Completed
Conditions
Enlarged Pores
Sebum Production
Interventions
Drug: Placebo
First Posted Date
2023-03-24
Last Posted Date
2024-08-23
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
31
Registration Number
NCT05784363
Locations
🇺🇸

Merz Investigation Site #0010473, Los Angeles, California, United States

🇺🇸

Merz Investigation Site #001097, Nashville, Tennessee, United States

🇺🇸

Merz Investigation Site #0010101, Coral Gables, Florida, United States

Longitudinal Evaluation and Real-world Evidence of NT201

Terminated
Conditions
Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face
Interventions
First Posted Date
2022-02-03
Last Posted Date
2023-06-07
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
11
Registration Number
NCT05222607
Locations
🇺🇸

SkinDC, Arlington, Virginia, United States

Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles

Not Applicable
Active, not recruiting
Conditions
Décolleté Wrinkles
Interventions
Device: Treatment with diluted Radiesse
First Posted Date
2021-12-20
Last Posted Date
2025-04-10
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
152
Registration Number
NCT05163353
Locations
🇺🇸

Clinical Testing of Beverly Hills, Merz Investigational Site #0010395, Beverly Hills, California, United States

🇺🇸

Facial Plastic Surgery, Merz Investigational Site #0010463, Redondo Beach, California, United States

🇺🇸

Private Practice, Merz Investigational Site #0010299, Santa Monica, California, United States

and more 6 locations

A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek

Not Applicable
Completed
Conditions
Cheek Volume Augmentation
Interventions
Device: Restylane Lyft Lidocaine
Device: VP1 Lido US
First Posted Date
2021-05-14
Last Posted Date
2023-05-24
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
202
Registration Number
NCT04886232
Locations
🇩🇪

Praxis für Hautkrankheiten, Merz Investigational Site #0490375, Drensteinfurt, Germany

🇩🇪

Hautmedizin Bad Soden, Merz Investigational Site #0490189, Bad Soden am Taunus, Germany

🇩🇪

Dermatologic Private Practice, Merz Investigational Site #0490345, Hamburg, Germany

and more 7 locations

Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

Not Applicable
Completed
Conditions
Improvement in Skin Laxity of the Lower Face and Submentum
Interventions
Device: Ultherapy treatment
Device: Untreated-control / delayed-treatment
First Posted Date
2021-03-12
Last Posted Date
2023-03-23
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
201
Registration Number
NCT04795622
Locations
🇨🇳

Peking University First Hospital, Merz Investigational Site #0860003, Beijing, China

🇨🇳

Shanghai 9th Hospital, Plastic Surgery, Merz Investigational Site #0860015, Shanghai, China

🇨🇳

Air Force General Hospital, Merz Investigational Site #0860002, Beijing, China

and more 2 locations

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

Not Applicable
Completed
Conditions
Décolleté Wrinkles
Interventions
Device: Octave-Ultherapy treatment
First Posted Date
2020-12-23
Last Posted Date
2024-01-18
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
99
Registration Number
NCT04681352
Locations
🇺🇸

Merz Investigational Site #0010416, Miami, Florida, United States

🇺🇸

Merz Investigational Site #0010352, Norwalk, Connecticut, United States

🇺🇸

Merz Investigational Site #0010395, Beverly Hills, California, United States

and more 7 locations

Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Moderate to Severe Nasolabial Folds

Not Applicable
Completed
Conditions
Correction of Moderate to Severe Nasolabial Folds (NLFs)
Interventions
Device: Radiesse injectable implant (dermal filler)
Device: Restylane injectable implant (dermal filler)
First Posted Date
2020-12-01
Last Posted Date
2023-01-23
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
134
Registration Number
NCT04647721
Locations
🇨🇳

Peking University Third Hospital, Merz Investigational Site #0860009, Beijing, China

🇨🇳

Peking University First Hospital, Merz Investigational Site #0860003, Beijing, China

🇨🇳

Zhejiang Provincial People's Hospital, Merz Investigational Site #0860005, Hangzhou, China

and more 4 locations

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines

Phase 3
Completed
Conditions
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
Interventions
Drug: Placebo
First Posted Date
2020-11-09
Last Posted Date
2024-08-06
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
368
Registration Number
NCT04622254
Locations
🇩🇪

Merz Investigational Site, Wuppertal, Germany

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines

Phase 3
Completed
Conditions
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
Interventions
Drug: Placebo
First Posted Date
2020-10-20
Last Posted Date
2024-05-08
Lead Sponsor
Merz North America, Inc.
Target Recruit Count
362
Registration Number
NCT04594213
Locations
🇺🇸

Merz Investigational Site, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath